You know what works, now push it further
You know what works, now push it further
The BioPhase 8800 system is a multi-capillary electrophoresis system that enables biopharma scientists to run multiple samples in parallel, accelerating the development and execution of sensitive, high-throughput analytical methods.
Take charge of the development pipeline, assess molecular liabilities more quickly, and enable rapid developability assessments to streamline the selection of candidates for progression into an effective therapy.
The BioPhase 8800 system is designed to advance your workflows into the next phase of biopharmaceutical development. With streamlined migration, consistent performance, and proven reliability, it’s the evolution that feels like home.
Gain valuable insights into quality attributes of biotherapeutics with kit-based assays and customizable features to address the evolving drug development pipeline. Ensure consistent, reproducible results with liquid temperature control, multiple injection modes, and simple switching between native fluorescence (NF), UV, or laser-induced fluorescence (LIF) detection modes.
Get to the answer sooner with a boost in throughput
Flexibility for your workflow requirements
Achieve consistent outcomes with precise temperature control
Stay flexible with precise injection control
Quick and easy results with intuitive, large touchscreen interface
Maximize productivity with kitted reagents and methods
Integrated optical detection on the BioPhase 8800 system eliminates the need for manual detector changes, enabling seamless switching between detection modules. Choose NF, UV, or LIF depending on workflow needs.
Gain faster and more confident peak integration with significantly increased signal-to-noise ratio and a stable baseline.
NF detection offers increased sensitivity compared to traditional UV detection for CE-SDS, cIEF, and CZE assays. Eliminate the need for protein-fluorescence-dye conjugation during sample preparation.
Non-reduced CE-SDS analysis of NIST
IgG with NF detection:
Improved signal-to-noise ratio with NF results in a stable baseline and up to 10X improvement in sensitivity, allowing for faster interpretation and integration of peaks.
Enable quantitation of low-level impurities
UV detection can struggle to identify low-level impurities due to interference from baseline noise. NF detection reduces the baseline noise and enables the quantitation of low-level impurities down to 0.01%.
Charge heterogeneity analysis of NISTmAb on the BioPhase 8800 system with NF. Achieve equivalent data between UV and NFD for cIEF with a more stable baseline to enable better peak integration and identification of low abundant species.
With kit-based CE workflows from SCIEX, your lab stays ready for what’s next, no rebuild required. Whether it’s a new modality, a shift in format, or an urgent timeline, respond without overhauling your system.
Discover how your peers in the biopharma world are rewriting the rules of CE in drug development. Wherever you play in the pipeline, change the game in modern medicine.
Reclaim time for innovation by identifying and advancing drug candidates more confidently with analytical strategies that support your team across modalities, from discovery to commercialization.
Break through barriers and extend the frontiers of mRNA, saRNA, and circRNA development with intuitive analytical solutions. Confidently innovate with high-quality, sensitive, and accurate data to assess integrity, purity, and CQAs.
Advance your projects with purpose-built solutions for the analysis of pDNA and dsDNA to support the development of your mRN), viral vectors, recombinant proteins, and other new modalities.
Optimize your processes with solutions that overcome the analytical challenges of viral vector-based drugs. Take control of full and empty ratios and protein and genome profiles. Break down the boundaries of protein and post-translational modification (PTM) characterization with dedicated high-resolution workflows offering unprecedented depth.
Set your own schedule for CRISPR/Cas9 gene editing with innovative, intuitive analytical solutions. Unleash the potential of your Cas9 mRNa, sgRNA, and Cas9 proteins by understanding quality, purity, and safety and assessing on/off target effects.
Set the pace with confidence. Cell line monitoring and analysis solutions verify the identity, purity, and stability of lead candidates with high throughput strategies that are ready for automation.
Fully understand drug candidate glycoprofiles with pipeline-specific solutions. Gather critical high-resolution information and site-specific data points with advanced glycan analysis for complex biologic development.
Pursue the end goal with confidence. Achieve the full picture and accelerate decisions with comprehensive characterization of biopharmaceutical charge variants.
Stay up-to-date with biopharma conversations on LinkedIn